Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Figure out How to Assess the Unwavering quality of SUVs for Seniors - 2Nodding off is dangerous. Some animals have evolved extreme ways to sleep in precarious environments
- 3Philippines evacuates 3,000 villagers after volcano activity raises alert level
- 4Israeli Chief of Staff declares new border with Gaza Strip
- 5'Every day I planned an escape': Ariel Cunio shares details of Hamas captivity
- The most effective method to Begin Your Excursion in Gold Venture
- Creative Style: 10 Architects Reclassifying the Business
- Barry Manilow to have surgery for early-stage lung cancer and postpones January concerts
- The Significance of Prenuptial Arrangements in Separation Procedures
- I'm an 83-year-old yoga instructor. I'm not your typical grandma — I still work to feel fulfilled and supplement my Social Security.
- Ageless Tastefulness: An Outline of Valuable Gemstones and Adornments
- New York to require social media platforms to display mental health warnings
- Figure out How to Ascertain the Restitution Time frame for Your Sunlight based chargers
- Passenger Missing After Going Overboard Disney Cruise Ship
